Paul Hudson
"Our strong performance since launching our Play to Win strategy, further exemplified by the progress of our growth drivers in Q3 and recent pipeline news flow, has given us an opportunity to take important steps for the future of our company."
https://www.sanofi.com/en/investors/fina...sults-2023
naja, 2024 und 2025 liegen wohl nicht in der Zukunft und was danach kommt steht in den Sternen.
könnte auch kommen wie bei Abbvie, was dort Humira, ist hier Dupixent
"Our strong performance since launching our Play to Win strategy, further exemplified by the progress of our growth drivers in Q3 and recent pipeline news flow, has given us an opportunity to take important steps for the future of our company."
https://www.sanofi.com/en/investors/fina...sults-2023
naja, 2024 und 2025 liegen wohl nicht in der Zukunft und was danach kommt steht in den Sternen.
könnte auch kommen wie bei Abbvie, was dort Humira, ist hier Dupixent
__________________
_________________________________________________________________________________________________
Corrections are usually over very quickly, and they're traditionally painless to long-term investors.
Experience is what you get, if you expect anything else!
Alles ist Zahl - die Vollkommenen --> 6; 28; 496; 8128; 33550336; 8589869056
Corrections are usually over very quickly, and they're traditionally painless to long-term investors.
Experience is what you get, if you expect anything else!
Alles ist Zahl - die Vollkommenen --> 6; 28; 496; 8128; 33550336; 8589869056